FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Scopolamine (Transderm Scop) Transdermal System Patch
Status: Resolved
»Duration of Shortage: 09/15/2016 - 11/03/2017
»Therapeutic Categories: Endocrinology/Metabolism; Neurology

Expand all

Sandoz (Revised 11/03/2017)

Company Contact Information:
800-525-8747

Presentation
  • Transderm (Scopolamine) 1.5 mg Patch 10 count (NDC 10019-553-01)
  • Transderm (Scopolamine) 1.5 mg Patch 24 count (NDC 10019-553-02)
  • Transderm (Scopolamine) 1.5 mg Patch 4 count (NDC 0067-4345-04)
Note:
  • Available

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English